Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic

NCT04460547 · clinicaltrials.gov ↗

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Convalescent Plasma Transfusion
DRUG: Hydroxychloroquine
DRUG: DAS181
DRUG: Ivermectin
DRUG: Interferon Beta-1A

Sponsor

Qassim University